New Market Research Report: Upper Respiratory Tract Disorders - Pipeline Review, H2 2012

Sept. 27, 2012 - PRLog -- Global Markets Direct's, 'Upper Respiratory Tract Disorders - Pipeline Review, H2 2012', provides an overview of the Upper Respiratory Tract Disorders therapeutic pipeline. This report provides information on the therapeutic development for Upper Respiratory Tract Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Upper Respiratory Tract Disorders. 'Upper Respiratory Tract Disorders - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/463738_upper_respiratory_tract_disorders_pipeline_review.aspx
------------------------------------------------------------

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Upper Respiratory Tract Disorders.
* A review of the Upper Respiratory Tract Disorders products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Upper Respiratory Tract Disorders pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Upper Respiratory Tract Disorders.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Upper Respiratory Tract Disorders pipeline depth and focus of Upper Respiratory Tract Disorders therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Upper Respiratory Tract Disorders Therapeutic Products under Development, Key Players in Upper Respiratory Tract Disorders Therapeutics, Upper Respiratory Tract Disorders Pipeline Overview, Upper Respiratory Tract Disorders Pipeline, Upper Respiratory Tract Disorders Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Upper Respiratory Tract Disorders Overview
Therapeutics Development
An Overview of Pipeline Products for Upper Respiratory Tract Disorders
Upper Respiratory Tract Disorders Therapeutics under Development by Companies
Upper Respiratory Tract Disorders Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Upper Respiratory Tract Disorders Therapeutics - Products under Development by Companies
Upper Respiratory Tract Disorders Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Upper Respiratory Tract Disorders Therapeutics Development
Alcon, Inc.
GlaxoSmithKline plc
Merck & Co., Inc.
Novartis Vaccines and Diagnostics, Inc.
OPKO Health, Inc.
Collegium Pharmaceutical, Inc.
Ahn-Gook Pharmaceutical Co., Ltd.
Verona Pharma Plc
Maywufa Company Limited
Lipocine Inc.
Afferent Pharmaceuticals, Inc.
AUS Bio Limited
Upper Respiratory Tract Disorders - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Rolapitant - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SB705498 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SCH 900978 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VRP-700 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AF-219 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PHN081 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Azithromycin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AG PPC709 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AG1321001SY - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AG NDT802 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
V501 + Menactra + Adacel - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Budesonide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BPZE1 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
COL-112 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
COL-131 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Epinephrine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
FP01 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AL53817 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Prednisone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GSK2339345 - Drug Profile
Product Description

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=4637...

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.